Hospital & Healthcare
60 recent notes from companies in this sector. 20 companies tracked.
Fortis Healthcare enters Odisha with asset-light hospital deal
The 300-bed O&M pact with Dion Group adds a greenfield presence in Cuttack, but for a ₹74,212 crore operator, it's one bed in a much larger portfolio.
KK Shah Hospitals brings first cardiac CT to Ratlam
The nano-cap hospital chain installs a 64-slice GE Revolution Evo at its new diagnostic centre, with a Siemens MRI to follow. But the filing carries zero financial details, leaving the investment impact unknown.
Unihealth pushes 1,000-bed target to 2028, Uganda still 82% of revenue
Earlier commitments on geographic mix and a Tanzania syringe plant have been abandoned. EBITDA margins are set to compress from low-40s to mid-30s as new beds add costs.
Park Medi World adds 100 beds to Gurugram hospital for ₹25 cr
Umkal Health Care approves 100-bed expansion of Park Hospital in Palam Vihar; operations by Nov 2026.
Global Health meets Enam — but says no price-sensitive news to share
Medanta operator holds one-on-one virtual meetings with IKIGAI Asset Manager on June 26 and Enam Asset Management on June 30. The company says no unpublished price-sensitive information will be discussed.
CDSCO suspends HCG ethics panel from new trials for 24 months
India's drug regulator bars HCG's KR Unit Ethics Committee from approving new clinical trials for failures in reporting serious adverse events. Hospital operations unaffected.
NG Industries' profit tumbles 78% as other income vanishes
Net profit falls to ₹173.38 lakhs from ₹773.95 lakhs, driven by collapse in investment income. Dividend of ₹3.50 per share recommended.
KIMS promoters inject ₹600 cr via warrants to retire debt, fund expansion
The preferential issue of 77 lakh warrants at ₹779 each amounts to 15% of revenue. Proceeds will reduce debt and bankroll greenfield hospitals as Q4 profit slumped 69%.
Constronics Infra gets qualified audit over ₹5.87 lakh seizure
The nano-cap's FY26 audited results include a qualified opinion for a seizure by an investigating agency, though the amount is just 0.01% of its ₹55 cr market cap.
Global Health lands LOI for 150-MBBS-seat college at Medanta Gurugram
The Haryana government's Letter of Intent clears the way for a teaching hospital; neither a timeline nor a capex figure was disclosed.
Star Imaging installs North India's first 1184-slice CT scanner in Delhi
The upgrade falls within the nano-cap company's guided ₹20-25 crore capex for the year. No separate cost was disclosed.
Kovai Medical's Joint MD Dr. Thavamani Devi dies, leaving no successor
The promoter and hospital leader held her post since 2000. Kovai says the loss is 'irreplaceable' and has not named a replacement.
Dr Lalchandani Labs posts profit only because lenders waived ₹61 lacs in debt
Auditors qualified the accounts, flagging NPA classification and unpaid statutory dues since mid-2024. The company holds ₹4.14 cr in cash but won't pay.
Lalchandani Labs auditors flag defaults despite cash reserves
Auditors issued a qualified opinion on FY26 results, documenting loan defaults and missed statutory dues even as the company held cash.
Dr Lalchandani Labs survives on a one-time settlement. Auditors qualify the accounts.
A ₹61.08 lacs one-time settlement gain is the only thing standing between the company and an operational loss. Auditors flagged NPA classification and unpaid statutory dues.
Yatharth Hospital sees 36% revenue jump, buys 250 beds in Gurugram
Q4 FY26 revenue hit ₹1,207 cr, up 36% YoY, with new Delhi and Faridabad facilities now contributing 11% of group sales. The company is acquiring a 250-bed hospital in Gurugram.
Unihealth's Ugandan receivables hit 320 days; Tanzania plant scrapped
FY26 profit surged 83%, but the 1,000-bed expansion is now three years late and a key African bet has been abandoned.
Shalby's Q4 call is a replay. The stock needs a new script.
The transcript details a MedTech turnaround and oncology capex plans, but the information was already in the prior earnings release.
Narayana Hrudayalaya's Q4 transcript adds no new data
The full transcript of the May 26 earnings call is a procedural filing. It contains no new financial information or strategic shifts beyond the concall summary already in the market.
Broach Lifecare doubles bed capacity with Gujarat health dept approval
A permanent registration certificate allows the Bharuch hospital to scale from 25 to 50 beds, a 100% increase in its operational base.
Shalby pulls back on franchises, bets on implants hitting ₹650 cr by 2030
The MedTech division posted its second straight quarter of positive EBITDA. Management is shelving franchise expansion to focus capital on core hospitals and its long-term implant target.
Nephrocare Health Services transcript adds no new material data
The Q4 and FY26 earnings call transcript confirms previously disclosed financial results and strategic outlooks.
Star Imaging targets 25-30% revenue growth in FY27
The diagnostic chain plans to deploy ₹20-25 crore in capex while maintaining a net cash position of ₹31 crore.
Asarfi Hospital cuts margin targets and delays capacity expansion
Management lowered EBITDA margin guidance to 23-25% and pushed its 500-bed capacity goal to 2028. The company cited no specific reason for the shift.
Suraksha Diagnostic transcript confirms previously issued FY27 guidance
The Q4 and FY26 earnings transcript adds no new material information to the company's previously disclosed financial results and outlook.
Dr. Agarwal's Health Care Q4 transcript adds no new data
The company's latest earnings call transcript recaps previously disclosed financial results and provides standard updates on the merger process.
Lotus Eye Hospital confirms FY26 results in routine filing
The board formally approved audited financial results for Q4 and FY26. This filing confirms data already disclosed to the market.
Lotus Eye Hospital swings to loss as expansion costs mount
A surge in debt and capital expenditure has eroded profitability, with full-year net profit dropping to ₹8.04 lakhs from ₹73.93 lakhs.
Lotus Eye Hospital swings to loss as expansion costs mount
A push to grow the branch network has hit the bottom line, with annual profit falling to ₹8.04 lakhs and a Q4 net loss of ₹31.95 lakhs.
Narayana's UK deal diluting profits. Northern expansion scrapped. Clinic losses flat.
Management admitted three prior assurances have broken. The UK acquisition is hitting EPS, clinic losses aren't falling, and the north India push is off.
Kovai's Q4 tax error understated profit by ₹3.67 cr
A calculation mistake in the tax line overstated the bill. The fix raises quarterly net profit by 6.1%, but the annual total doesn't change.
Yatharth Hospital hits speed bumps in Agra and expansion plans
Management targets 26% revenue growth for FY27, but delays in brownfield projects and missed ARPOB targets in Agra temper the outlook.
Kovai fixes a tax math error, lifting Q4 profit by ₹3.67 cr
A calculation mistake in the final quarter's tax expense added 6.1% to net profit. The full-year results are untouched.
Choksi Labs posts 29% profit growth in FY26. Routine results.
Revenue grew 10% to ₹46.22 crore while net profit expanded 29% to ₹1.96 crore. The annual results were anticipated.
Star Imaging's FY26 revenue is flat at ₹50 cr. Profit barely moved.
The nano-cap diagnostics firm reported near-identical results to last year. Revenue held at ₹5,002.53 lakhs, net profit inched up 2%.
Star Imaging cuts FY27 growth guidance after licensing delays
Revenue growth is now targeted at 25-30%, down from an earlier 30-35% goal. Two new centres are live, with a third in New Delhi due within two months.
Chennai Meenakshi hospital slips to Q4 loss, but full-year red ink narrows
The nano-cap hospital's quarterly profit turned to a loss of ₹2.13 lakhs. For the full year, the net loss improved from ₹137.37 lakhs to ₹111.72 lakhs.
Narayana Hrudayalaya clears FY26 results and debt plans
Board finalizes previously disclosed results, approves a ₹1,500 cr debt raise, and holds the dividend steady.
Narayana Hrudayalaya confirms FY26 numbers as expected
The health provider's full-year results add no new data, showing the impact of the UK acquisition already priced in by the market.
Narayana Hrudayalaya consolidated revenue jumps 44% on UK acquisition
Standalone growth hit 10.7% as the company integrated Practice Plus Group; dividend remains flat at ₹4.50.
Narayana Hrudayalaya consolidated revenue jumps 44% on UK acquisition
Standalone net profit rose 16.7% as the company closed its first full year following the November 2025 entry into the UK market.
Narayana Hrudayalaya grows profit 17% in FY26
The hospital chain posts steady annual growth and secures a ₹1,500 crore debt-raising limit.
Fortis Healthcare reports 31.5% profit growth for FY26
A routine regulatory filing confirms previously released annual figures and declares a ₹1 per share final dividend.
Fortis Healthcare profits climb 31% on double-digit revenue growth
FY26 consolidated revenue hit ₹9,128 crore, with the board proposing a final dividend of ₹1 per share.
Fortis Healthcare confirms final dividend of ₹1 per share
The company cleared routine year-end business, including cost auditor appointments and CSR policies, following its earlier earnings release.
Fortis Healthcare reports steady results with no surprises
The company’s investor presentation confirms earlier Q4 disclosures, with revenue growing 17.8% and EBITDA margins steady at 22.5%.
Fortis Healthcare profit hits ₹1,064 crore as hospital revenue jumps
Annual revenue reached ₹9,128 crore, led by a 19.1% gain in hospital income, with the board declaring a dividend of ₹1 per share.
Fortis Healthcare profit climbs 31.5% to ₹1,064 crore in FY26
Consolidated revenue grew 17.3% as the hospital chain wrapped its fiscal year with an unmodified audit opinion.
Fortis Healthcare approves Q4 results and a ₹1 dividend
The company posted year-on-year growth for FY2026, but the filing contains no material surprises for investors.
Kovai Medical Center confirms final dividend of ₹15 per share
The hospital operator formalised its FY25-26 annual results after prior disclosure.
Kovai Medical Center lifts dividend by 37% after FY26 profit gains
The hospital operator grew net profit by 17% to ₹244.5 crore, backed by rising patient volumes and a growing education business.
Star Imaging reports stagnant FY26 revenue of ₹5,002 lakhs
The diagnostic firm posted a modest profit increase while top-line growth remained effectively flat for the fiscal year.
GPT Healthcare earnings drag as new Raipur facility losses bite
Revenue grew 15% to ₹478.5 crore, but profits slumped as the company absorbed startup costs at its newest hospital.
KIMS plans ₹1,500 cr QIP as profit slides 69% on expansion drag
Revenue grew 35% to ₹1,084 cr, but new units in Bangalore, Thane, and Nasik burned ₹32 cr in EBITDA this quarter.
Suraksha Diagnostic cools growth targets to 15% for FY27
Management pivots on performance metrics while shifting toward public-private partnerships, drawing scrutiny.
Max Healthcare delays Gurgaon hospital, cuts oncology revenue outlook
Management now expects the 500-bed Gurgaon facility by end-FY27, not H1. Oncology's share of revenue is seen stabilising at 21-22%, down from a prior 25-26%.
Suraksha's revenue grew 22.5%, but profit fell 14% in Q4.
Full-year profit grew just 1.4% as margin compression from network expansion ate into the top line.
Dr. Agarwal's Health Care reports FY26 revenue of over ₹2,000 cr
The company confirms FY26 growth targets with plans to add 60 new facilities in FY27 at a cost of up to ₹400 cr.
Suraksha Diagnostic revenue lifts 21% as margins tighten
FY26 revenue climbs to ₹300.68 cr while profit growth stalls at 1.9%. The board initiates a ₹0.50 dividend.
Broach Lifecare revenue doubles, yet profit craters 84%
Operating costs and employee expenses swallowed the gains, pushing the hospital operator into a second-half loss of ₹22.53 lakh.